• Inventors:
  • Assignees:
  • Publication Date: December 31, 1969
  • Publication Number:

Abstract

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)

    Title

Cited By (41)

    Publication numberPublication dateAssigneeTitle
    US-2006182781-A1August 17, 2006Allergan, Inc.Methods for treating ocular conditions with cyclic lipid contraining microparticles
    US-2006246145-A1November 02, 2006Allergan, Inc.Methods for treating ocular conditions with cyclic lipid containing microparticles
    US-2006286173-A1December 21, 2006Kazuhito Yamada, Yasumasa Sasaki, Hiroyuki Sakai, Kiyoshi MatsunoDrug delivery system for sub-tenon s capsule adminstration of fine grains
    US-2007260201-A1November 08, 2007Georgia Tech Research Corporation, Emory UniversityMethod for drug delivery to ocular tissue using microneedle
    US-2008166417-A1July 10, 2008Kazuhito Yamada, Tokie Oohashi, Hiroyuki Sakai, Kiyoshi MatsunoMethod of Relieving or Avoiding Side Effect of Steroid
    US-2009017097-A1January 15, 2009Sawhney Amarpreet S, Ransone Ii William HHydrogel polymeric compositions and methods
    US-2009036552-A1February 05, 2009Santen Pharmaceutical Co. Ltd.Noninvasive Drug Delivery System To Tissue of Posterior Segment of Eye Using Solid Composition
    US-2010256597-A1October 07, 2010Emory University, Georgia Tech Research CorporationMethods and Devices for Drug Delivery to Ocular Tissue Using Microneedle
    US-2010278898-A1November 04, 2010Allergan, Inc.Intraocular pressure reduction with intracameral bimatoprost implants
    US-7589057-B2September 15, 2009Allergan, Inc.Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
    US-7918814-B2April 05, 2011Georgia Tech Research Corporation, Emory UniversityMethod for drug delivery to ocular tissue using microneedle
    US-8197435-B2June 12, 2012Emory University, Georgia Tech Research CorporationMethods and devices for drug delivery to ocular tissue using microneedle
    US-8409606-B2April 02, 2013Incept, LlcDrug delivery through hydrogel plugs
    US-8563027-B2October 22, 2013Incept, LlcDrug delivery through hydrogel plugs
    US-8636713-B2January 28, 2014Emory University, Georgia Tech Research CorporationMethods and devices for drug delivery to ocular tissue using microneedle
    US-8673341-B2March 18, 2014Allergan, Inc.Intraocular pressure reduction with intracameral bimatoprost implants
    US-8722097-B2May 13, 2014Allergan, Inc.Oil-in-water method for making polymeric implants containing a hypotensive lipid
    US-8808225-B2August 19, 2014Emory University, Georgia Tech Research CorporationMethods and devices for drug delivery to ocular tissue using microneedle
    US-8900622-B1December 02, 2014Allergan, Inc.Hypotensive lipid-containing biodegradable intraocular implants and related methods
    US-8961501-B2February 24, 2015Incept, LlcMethod for applying flowable hydrogels to a cornea
    US-9101583-B2August 11, 2015Allergan, Inc.Microparticles manufactured in an oil-in-water process comprising a prostamide
    US-9125807-B2September 08, 2015Incept LlcAdhesive hydrogels for ophthalmic drug delivery
    US-9180047-B2November 10, 2015Clearside Biomedical, Inc.Apparatus and methods for ocular injection
    US-9326949-B2May 03, 2016Allergan, Inc.Method of making oil-in-oil emulsified polymeric implants containing a hypotensive lipid
    US-9370485-B2June 21, 2016Incept, LlcHydrogel polymeric compositions and methods
    US-9393223-B2July 19, 2016Allergan, Inc.Hypotensive lipid-containing biodegradable intraocular implants and related methods
    US-9539139-B2January 10, 2017Clearside Biomedical, Inc.Apparatus and methods for ocular injection
    US-9572800-B2February 21, 2017Clearside Biomedical, Inc.Methods and devices for the treatment of ocular diseases in human subjects
    US-9636253-B1May 02, 2017Clearside Biomedical, Inc.Apparatus and methods for ocular injection
    US-9636332-B2May 02, 2017Clearside Biomedical, Inc.Methods and devices for the treatment of ocular diseases in human subjects
    US-9669039-B2June 06, 2017Allergan, Inc.Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
    US-9707238-B2July 18, 2017Allergan, Inc.Oil-in-water method for making polymeric implants containing a hypotensive lipid
    US-9750751-B2September 05, 2017Allergan, Inc.Hypotensive lipid-containing biodegradable intraocular implants and related methods
    US-9770361-B2September 26, 2017Clearside Biomedical, Inc.Apparatus and methods for ocular injection
    US-9775846-B2October 03, 2017Allergan, Inc.Hypotensive lipid-containing biodegradable intraocular implants and related implants
    US-9775906-B2October 03, 2017Incept LlcHydrogel polymeric compositions and methods
    US-9788995-B2October 17, 2017Georgia Tech Research Corporation, Emory UniversityMethods and devices for drug delivery to ocular tissue using microneedle
    US-D750223-SFebruary 23, 2016Clearside Biomedical, Inc.Medical injector for ocular injection
    WO-2007131050-A2November 15, 2007Georgia Tech Research Corporation, Emory UniversityMethod for drug delivery to ocular tissue using microneedle
    WO-2007131050-A3February 14, 2008Georgia Tech Res Inst, Univ Emory, Mark R Prausnitz, Ninghao Jiang, Henry F EdelhauserMethod for drug delivery to ocular tissue using microneedle
    WO-2013006574-A1January 10, 2013Vanderbilt UniversitySurfactant ported device for treatment of blepharitis and applications of same